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Background: Serum gamma-glutamyltransferase (GGT) has been suggested as a predictor for development of the metabolic 
syndrome in non-Korean population, but studies in Korean population are scarce. Therefore, we examined the association 
between serum GGT levels and the incidence of the metabolic syndrome in Korean male offi   ce workers.
Methods: The study population consisted of 32,692 office workers who underwent health checkups in both 2005 and 2009. 
A total of 17,583 with elevated GGT levels, the presence of metabolic syndrome, medication history at baseline, and female 
offi   ce workers were excluded. Finally, 15,109 subjects were included in the fi  nal analysis. We measured serum GGT levels and 
individual metabolic components.
Results: As a quartile of serum GGT increased, 4-year follow-up incidence of the metabolic syndrome increased. After adjustment 
for age, alcohol drinking status and smoking status in 2005, logistic regression analysis showed that the odds ratios (95% 
confi  dence interval) for incident metabolic syndrome in 2009 compared to the lowest quartile and upper quartiles were 1.00 
(reference), 1.57 (1.24-2.00), 2.73 (2.17-3.43), 3.78 (3.02-4.74), and statistically signifi  cant (P < 0.001), respectively.
Conclusion: These results showed that the higher serum GGT predicted the future development of metabolic syndrome. In 
Korean male offi   ce workers without the metabolic syndrome, the serum GGT levels despite normal levels were associated with 
an increased risk of incident metabolic syndrome.
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INTRODUCTION
The common clustering of abdominal obesity, hyper-
triglyceridemia, low high density lipoprotein cholesterol 
(HDL-C), high blood glucose level and hypertension is referred 
to as metabolic syndrome (MetS), which is closely related to an 
increased risk for type 2 diabetes and cardiovascular disease. Th  e 
prevalence of MetS in Korean male population over 30 years of 
age increased from 29.6% in 1998, 31.5% in 2001, and 33.5% 
in 2005, whereas in Korean female population over 30 years of Byung-Seong Suh: GGT and Metabolic Syndrome in Offi   ce Workers
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age decreased from 30.3% in 1998, 33.0% in 2001, and 26.5% in 
2005.
1) Th   is could indicate an increasing trend in the prevalence 
of MetS among male Korean population and might be related 
to westernized lifestyle of Korean population, especially in male 
offi   ce workers.
Serum gamma-glutamyltransferase (GGT) has been used 
widely as an index of alcohol intake or liver dysfunction,
2) and has 
been one of the item as a part of national health checkup program 
in Korea. Previous studies suggest that GGT is closely related 
to risk factors for cardiovascular disease, hypertension, type 2 
diabetes, and MetS.
3,4) Recently a cross-sectional study among 
the Korean population reported an association between GGT, 
MetS components and insulin resistance.
5) Additionally, elevated 
GGT concentrations are related to older age, male, smoking and 
physical inactivity, hypertension, hypertriglyceridemia, and low 
HDL-C.
6-8)
The role of GGT is maintaining adequate levels of intra-
cellular glutathione and serum GGT has been proposed as 
a marker of oxidative stress.
9) Serum GGT may be strongly 
associated with obesity or fat accumulation of liver and 
contributing to the development of insulin resistance.
10) Recent 
study showed that high GGT was an independent and early 
predictor for chronic disorders as well as cardiovascular disease.
11)
Even though there are some cross-sectional studies regarding 
the association between GGT and MetS, longitudinal studies 
which can show a temporal relationship are scarce among the 
Korean population. Therefore, we hypothesized that GGT 
is a predictor for future development of MetS. We examined 
the association between GGT within normal range and the 
development of MetS among MetS-free male Korean workers. 
After 4 years, we analyzed the cumulative incidence of MetS in 
2009 and investigated on how elevated GGT infl  uenced MetS.
METHODS
1. Study Population
The study population was comprised of male workers who 
underwent a health checkup program in both 2005 and 2009. A 
total of 76,984 and 98,423 individuals participated in the health 
checkup in 2005 and 2009, respectively. Among them, 32,692 
individuals with both laboratory results and questionnaire were 
considered for this study. We selected only office male workers 
and excluded 9,374 non-offi   ce workers and 1,557 female workers. 
We further excluded 1,011 subjects with hepatitis, chronic liver 
disease, malignancy, and renal failure and 3,305 subjects with 
MetS or with current medication history for hypertension or 
diabetes mellitus. Finally, a total of 3,341 with abnormal GGT 
levels defi  ned as GGT of > 63 IU/L were excluded and 15,109 
subjects were included for analysis.
2. Measurements
Health checkup examinations included data on medical 
history, medication use, health-related behaviors, anthropometric 
and physical measurements, and blood biochemical measurements. 
Body weight was measured with light clothing and without shoes 
to the nearest 0.1 kg using a digital scale. Height was measured 
to the nearest 0.1 cm. Body mass index (BMI) was calculated as 
weight in kilograms divided by height in meters squared. Trained 
Table 1. Characteristics of the study subjects in 2005.
Variables Men (n = 15,109)
Age (y) 41.3 ± 5.9
GGT (IU/L)  28.1 ± 13.2
BMI (kg/m
2) 23.8 ± 2.6
TG (mg/dL) 127.1 ± 65.9
HDL-C (mg/dL) 50.7 ± 9.9
SBP (mm Hg) 112.8 ± 12.8
DBP (mm Hg) 75.7 ± 8.6
Glucose (mg/dL)  95.1 ± 11.1
Drinking status 
None  2,691 (17.8)
≤1-2 times/wk 11,206 (74.2)
>2 times/wk 1,212 (8.0)
Smoking status
None  5,331 (35.3)
Ex-smoking  3,809 (25.2)
Smoking  5,969 (39.5)
Values are presented as mean ± SD or number (%).
GGT: gamma glutamyltransferase, BMI: body mass index, TG: 
triglyceride, HDL-C: high density lipoprotein cholesterol, SBP: 
systolic blood pressure, DBP: diastolic blood pressure. Byung-Seong Suh: GGT and Metabolic Syndrome in Offi   ce Workers
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nurses measured sitting blood pressure (BP) with a mercury 
sphygmomanometer. 
Blood specimens were sampled from the antecubital vein 
after more than 12 hours of fasting. Serum levels of fasting 
glucose, triglycerides, HDL-C, and GGT were measured using 
Bayer Reagent Packs on an automated chemistry analyzer (Advia 
1650 Autoanalyzer; Bayer Diagnostics, Leverkusen, Germany). 
Fasting glucose was measured using Hexokinse method (Hitachi 
747 automatic analyzer, Hitachi, Japan). The clinical laboratory 
has been accredited and participates annually in inspections 
and surveys by the Korean Association of Quality Assurance for 
Clinical Laboratories.
3. Definition of Metabolic Syndrome
MetS was defined using the modified National Cholesterol 
Education Program Adult Treatment III
12) as the presence of 3 or 
more among the following criteria: 1) abdominal obesity;
13) 2) 
fasting blood glucose 110 mg/dL; 3) triglycerides 150 mg/dL; 4) 
HDL-C < 40 mg/dL; and 5) BP ≥ 130/85 mm Hg. Triglycerides, 
HDL-C, glucose, and BP were determined at each visit. Because 
measurement of waist circumference was not available for all 
subjects, we substituted abdominal obesity with overall adiposity 
for BMI of ≥ 25 kg/m
2, which has been proposed as a cut-off   for 
the diagnosis of obesity in Asian populations.
13) Current user of 
blood glucose lowering agents was considered as having diabetes 
mellitus and current user of BP lowering agents was considered 
as having hypertension.
4. Statistical Analyses
The statistical analysis of the data was carried out using 
PAWS ver. 18.0 (SPSS Inc., Chicago, IL, USA). Student t-test 
were used to compare the characteristics of participants, which 
are age, triglyceride, HDL-C, systolic blood pressure (SBP), 
diastolic blood pressure (DBP), fasting glucose, and baseline 
GGT quartiles. χ
2-tests were used to compare alcohol drinking 
status and smoking status. We analyzed trend test according to the 
4 groups of GGT quatiles. We analyzed the cumulative incidence 
of MetS in 2009 according to the 4 groups of GGT quartiles in 
2005. We analyzed the adjusted odds ratios (and 95% confi  dence 
intervals) for incident MetS comparing the highest three quartiles 
of the baseline (in 2005) serum GGT to the lowest quartile 
using logistic regression analyses. Age, alcohol drinking status, 
and smoking status were adjusted as possible confounders in the 
model. All reported P-values are two tailed, and those < 0.05 were 
considered statistically signifi  cant.
RESULTS
1. Clinical Characteristics of the Subjects
Th   e basic characteristics of the study subjects are presented in 
the 15,109 male offi   ce workers (Table 1). Th   e average age of the 
Table 2. Characteristics according to the quartiles of serum GGT in 2005.
Variables
1st quartile 2nd quartile 3rd quartile 4th quartile
P for trend
1-17 (IU/L) 18-25 (IU/L) 26-36 (IU/L) 37-63 (IU/L)
Number 3,648 4,124 3,673 3,664 <0.001
Age (y) 40.4 ± 5.9 41.0 ± 5.8 41.8 ± 5.9 42.0 ± 5.7 <0.001
BMI (kg/m
2) 22.7 ± 2.4 23.4 ± 2.4 24.2 ± 2.5 24.8 ± 2.5 <0.001
TG (mg/dL)  99.9 ± 47.4 118.7 ± 59.2 136.2 ± 66.8 154.6 ± 75.0 <0.001
HDL-C (mg/dL)  51.4 ± 10.2  50.9 ± 10.1 50.2 ± 9.7 50.2 ± 9.5 <0.001
SBP (mm Hg) 110.5 ± 12.8 112.5 ± 12.6 113.7 ± 12.8 114.5 ± 12.7 <0.001
DBP (mm Hg) 73.8 ± 8.4 75.3 ± 8.3 76.5 ± 8.5 77.2 ± 8.6 <0.001
Glucose (mg/dL) 93.2 ± 9.3  94.7 ± 11.4  95.7 ± 11.5  96.7 ± 11.7 <0.001
Values are presented as mean ± SD.
GGT: gamma glutamyltransferase, BMI: body mass index, TG: triglyceride, HDL-C: high density lipoprotein cholesterol, SBP: systolic blood 
pressure, DBP: diastolic blood pressure.Byung-Seong Suh: GGT and Metabolic Syndrome in Offi   ce Workers
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subjects was 41.3 years. Th   e average BMI and blood pressure were 
23.8 kg/m
2 and 112.8/75.7 mm Hg, respectively. Th  e  percentage 
of alcohol drinking status, which was more than 2 times per week, 
presented 8.0% and current smoking status presented 39.5%.
2. Clinical Characteristics According to the 
Quartiles of Serum GGT
The subjects were classified according to the quartiles of 
serum GGT (≤ 63 IU/L in 2005), and their MetS components in 
2005 were compared (Table 2). Th   e categories of the 4 quartiles 
of serum GGT were 1-17 IU/L, 18-25 IU/L, 26-36 IU/L, 
and 37-63 IU/L, respectively. The numbers of 4 quartiles of 
serum GGT were 3,648 (24.1%), 4,124 (27.3%), 3,673 (24.3%), 
and 3,664 (24.3%), respectively. The trend of age, BMI, GGT, 
triglyceride, SBP, and DBP increased from the first quartile to 
the fourth quartile (P < 0.001). HDL-C decreased from the fi  rst 
quartile to the fourth quartile (P < 0.001).
The subjects were classified according to the 4 quartiles of 
serum GGT (≤ 63 IU/L in 2005), and their MetS components 
in 2009 were compared (Table 3). Th   e trend of age, BMI, GGT, 
triglyceride, SBP, and DBP increased from the first quartile to 
the fourth quartile (P < 0.001). HDL-C decreased from the fi  rst 
quartile to the fourth quartile (P < 0.001).
3. Cumulative Incidence and Odds Ratios of 
MetS According to the 4 Quartiles of Serum 
GGT
We defined incidence of MetS as the percentage of newly 
number in MetS in 2009/number of MetS-free and GGT in 
normal levels in 2005. Total percentage (number) of incidence of 
MetS were 7.4% (1,113). Th   e respective percentage (number) of 
cumulative incidence were 3.4% (123), 5.4% (221), 8.8% (325), 
Table 3. Characteristics according to the quartiles of serum GGT in 2009.
Variables
1st quartile 2nd quartile 3rd quartile 4th quartile
P for trend
1-17 (IU/L) 18-25 (IU/L) 26-36 (IU/L) 37-63 (IU/L)
Number 3,648 4,124 3,673 3,664 <0.001
BMI (kg/m
2) 22.9 ± 2.4 23.6 ± 2.4 24.3 ± 2.5 24.9 ± 2.6 <0.001
TG (mg/dL) 111.2 ± 59.7 127.7 ± 67.8 144.2 ± 73.5 162.4 ± 91.0 <0.001
HDL-C (mg/dL)  53.5 ± 11.2  53.1 ± 11.0  51.8 ± 10.7  51.7 ± 10.5 <0.001
SBP (mm Hg) 113.6 ± 10.8 115.0 ± 10.7 116.0 ± 10.9 117.0 ± 11.0 <0.001
DBP (mm Hg) 73.8 ± 7.9 74.8 ± 8.1 75.7 ± 8.2 76.4 ± 8.4 <0.001
Glucose (mg/dL)  95.0 ± 12.3  96.5 ± 12.1  97.6 ± 12.4  99.1 ± 13.9 <0.001
Values are presented as mean ± SD.
GGT: gamma glutamyltransferase, BMI: body mass index, TG: triglyceride, HDL-C: high density lipoprotein cholesterol, SBP: systolic blood 
pressure, DBP: diastolic blood pressure.
Table 4. Cumulative incidence of metabolic syndrome according to the quartiles of serum GGT.
Variables
1st quartile 2nd quartile 3rd quartile 4th quartile
1-17 (IU/L) 18-25 (IU/L) 26-36 (IU/L) 37-63 (IU/L)
Number 3,648 4,124 3,673 3,664
Metabolic syndrome
Number 123 221 325 444
Incidence* 3.4 5.4 8.8 12.1
GGT: gamma glutamyltransferase.
*Cumulative incidence (%, incidence case of metabolic syndrome subjects among total subjects of each quartile during the follow-up). Byung-Seong Suh: GGT and Metabolic Syndrome in Offi   ce Workers
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and 12.1% (444), as quartiles, respectively. As higher the GGT 
quartile, the percentage of incidence of MetS increased (Table 4).
To confi rm that the higher GGT quartile increased incident 
MetS more than the lower GGT quartile, we adjusted age, alcohol 
drinking status and smoking status in 2005. We analyzed the 4 
GGT quartiles according to MetS by logistic regression. Th  e  odds 
ratios (confi  dence interval) of MetS were 1.57 (1.24-2.00), 2.73 
(2.17-3.43), and 3.78 (3.02-4.74), respectively, and statistically 
significant (P < 0.001). The positive association between the 
baseline GGT levels and incident MetS was observed (P < 0.001). 
The odds ratio of alcohol drinking status was not statistically 
significant (P > 0.05). The odds ratios of current and past 
smoking status were higher than non-smoking status (Table 5).
DISCUSSION
In numerous studies, the relationship between GGT and 
various diseases such as cardiovascular disease, hypertension and 
diabetes mellitus was proven to be relevant and henceforth, it was 
shown to be useful in predicting development of MetS. Unlike 
the other existing cross-sectional studies, this study investigated 
the factors that have an effect on the development of MetS by 
carrying out a longitudinal study (from 2005 to 2009) that looked 
into male subjects who completed medical examination showing 
MetS-free and a normal range of GGT; the normal range of 
GGT was divided into 4 quartiles, and the factors that infl  uenced 
MetS were investigated 4 years later. As a result of this study, even 
though the subjects were within the normal range of GGT, the 
higher GGT quartiles were shown to have MetS similarly at a 
higher rate, than the ones in the lower quartiles aft  er 4 years of the 
initial carrying out of the study. Th   is suggests that there is a close 
relationship between an increase of GGT and MetS.
According to the results of the study after 4 years, the 
incidence rate of MetS in 2009 was 7.4%, which is lower than the 
result of a study that investigated subjects without MetS after 3 
years
14) with 10.72% rate. However, the incidence rate of MetS 
could have been high as the study investigated 429 subjects, were 
relatively small number of subjects, and the average age was high 
with 48.2.
According to the results of each variable of MetS compared 
with the serum GGT divided into 4 quartiles, both in 2005 
Table 5. Adjusted odds ratios and 95% conﬁ  dence interval in the quartiles of serum GGT level for the incidence of metabolic syndrome by 
logistic regression analysis.
Variables* Odds ratio 95% conﬁ  dence interval P-value
GGT
1st quartile 1.00 Reference -
2nd quartile 1.57 1.24-2.00 <0.001
3rd quartile 2.73 2.17-3.43 <0.001
4th quartile 3.78 3.02-4.74 <0.001
Age (y) 1.03 1.02-1.04 <0.001
Drinking status in 2005
None 1.00 Reference -
≤1-2 times/wk 0.89 0.75-1.05  0.082
>2 times/wk 0.74 0.57-0.96  0.173
Smoking status in 2005
None 1.00 Reference -
Ex-smoker 1.12 0.95-1.33 <0.001
Current smoker 1.32 1.14-1.53 <0.001
GGT: gamma glutamyltransferase.Byung-Seong Suh: GGT and Metabolic Syndrome in Offi   ce Workers
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and 2009 results showed that the higher the quartile of serum 
GGT, age, triglyceride, SBP, DBP, and fasting glucose similarly 
increased which were statistically significant. The higher the 
quartile of serum GGT, only HDL-C was similarly decreased 
and statistically signifi  cant. MetS components were considerably 
under the infl  uence of GGT.
According to the result of a research in Framingham Heart 
Study that tracked records of subjects without MetS for 19 
years,
15) MetS increased in the case of a high GGT rate during the 
observation period. Furthermore, in the case of a research that 
observed subjects with a normal GGT for 3 years,
14) compared to 
the basal GGT 1 quartile, the study showed similar results with 
an increased rate of 2.28, 1.53, and 4.56 times, age 1.06 times and 
drinking status 1.35 times, respectively. However, in the present 
study alcohol has shown diff  erent results. Th   ere was a limitation 
to this research as the survey on alcohol drinking status merely 
asked a question on the frequency that a person consumes 
alcoholic drink per week. Th   e similar results were not att  ainable 
for smoking status, as the information analyzed was categorized 
merely into non-smokers, past smokers and current smokers.
According to the data from an Epidemiological Study on the 
Insulin Resistance Syndrome (Canadian Intercollegiate Sport 
Injury Registry),
16) it showed similar results 1.96, 2.25, and 3.81 
compared to the basal GGT 1 quartile, even aft  er an adjustment 
of variables such as age, drinking, smoking, and exercise status. 
From this research, it is also evident that within a normal range 
group, the higher GGT, the more risks it has of gett  ing MetS.
From this research, it is also evident that within a normal 
range group, the higher GGT rate, the more risks it has of gett  ing 
MetS. This shows a close correlation between GGT and MetS, 
and it would mean even within a range group with a normal GGT 
without MetS, the higher GGT rate, the more risk it has of gett  ing 
MetS hereaft  er.
Rutt  mann et al.
17) carried out a cross-sectional and longitudinal 
study against 163,944 Australians and concluded that GGT is 
a risk factor for cardiovascular disease and in the highest GGT 
quartile, the number of people with vascular disease increased 
64 percent for males, and 51 percent for females, respectively. In 
particular, it was confi  rmed that GGT is a key dependent variable 
for the death caused by cardiovascular failure due to chronic heart 
disease. Kazemi-Shirazi et al.
18) also carried out a longitudinal 
study against 283,438 participants for 12 years, and suggested that 
even within the normal group, the highest GGT quartile increases 
the cause of death by 100% and therefore, GGT is a strong factor 
for long-term survival.
There are not enough records that explain the correlation 
between MetS and GGT, but the first record shows that the 
high GGT in a normal scope is an expression of non-alcoholic 
fatt  y liver that is closely related to the deposit of visceral fat and 
obesity.
11) The second record states that the increase of GGT 
causes inflammatory reaction and such reaction hinders not 
only the metabolism of insulin of a liver but also of a number 
of other organs.
19,20) Th   e third record argues that the increase of 
GGT results from an oxidative stress and it plays a key role in the 
revelation of diabetes mellitus and MetS.
21)
Th   is study is signifi  cant that unlike the other cross-sectional 
studies carried out with only a few numbers of subjects, it was 
a four-year retrospective cohort research with a large number 
of subjects. Unlike other studies, the observation of incidence 
is possible, so it should provide important information on the 
concentration of GGT and the development of MetS.
The limitation of this study is firstly that it is based on data 
from medical examinations of only one university hospital and 
a categorized group, office workers and they cannot represent 
the whole population. Secondly, the investigations of the factors 
that can influence GGT and the development of MetS such as 
the ability of taking drugs, diet habit, and alcohol drinking status 
and smoking status are inadequate. Th   irdly, because serum GGT 
can increase in the case of subclinical liver disorder, such subjects 
could have been included in the study. Fourthly, observation 
period is only four years and needs a long-term observation. 
Hence, a more successful research will be achieved if a foothold is 
gained for a long-term large scale prospective research through a 
cooperative study between numerous institutions complementing 
the above-mentioned limitations.
To conclude, the study shows that even in a group without a 
presence of MetS and the basal GGT at a normal level, the basal 
GGT belongs to a higher group that has a greater risk of gett  ing 
MetS. Furthermore, it implies that GGT is related to a risk factor 
of cardiovascular diseases that triggers MetS and an increase of 
serum GGT can be henceforth a useful factor in predicting the 
development of MetS. Byung-Seong Suh: GGT and Metabolic Syndrome in Offi   ce Workers
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